These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24922297)

  • 1. The social burden and quality of life of patients with haemophilia in Italy.
    Kodra Y; Cavazza M; Schieppati A; De Santis M; Armeni P; Arcieri R; Calizzani G; Fattore G; Manzoli L; Mantovani L; Taruscio D
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s567-75. PubMed ID: 24922297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of severe haemophilia in Europe: the CHESS study.
    O'Hara J; Hughes D; Camp C; Burke T; Carroll L; Diego DG
    Orphanet J Rare Dis; 2017 May; 12(1):106. PubMed ID: 28569181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
    Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres.
    Nerich V; Tissot E; Faradji A; Demesmay K; Bertrand MA; Lorenzini JL; Briquel ME; Pouzol P; Woronoff-Lemsi MC
    Pharm World Sci; 2008 Jun; 30(3):287-92. PubMed ID: 18085428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilia A: health and economic burden of a rare disease in Portugal.
    Café A; Carvalho M; Crato M; Faria M; Kjollerstrom P; Oliveira C; Pinto PR; Salvado R; Dos Santos AA; Silva C
    Orphanet J Rare Dis; 2019 Sep; 14(1):211. PubMed ID: 31484564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
    Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective.
    Lorenzoni V; Triulzi I; Turchetti G
    BMC Health Serv Res; 2018 Aug; 18(1):596. PubMed ID: 30071878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome.
    Kodra Y; Cavazza M; de Santis M; Guala A; Liverani ME; Armeni P; Masini M; Taruscio D
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824402
    [No Abstract]   [Full Text] [Related]  

  • 15. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
    Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
    Orphanet J Rare Dis; 2022 Apr; 17(1):150. PubMed ID: 35379284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.
    Lopez-Bastida J; Aranda-Reneo I; Rodríguez-Sánchez B; Peña-Longobardo LM; Ye X; Laeis P; Fronk EM; Palmerini E; Leithner A; Van de Sande MAJ
    Orphanet J Rare Dis; 2021 Jul; 16(1):294. PubMed ID: 34215312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr.
    Molho P; Rolland N; Lebrun T; Dirat G; Courpied JP; Croughs T; Duprat I; Sultan Y
    Haemophilia; 2000 Jan; 6(1):23-32. PubMed ID: 10632738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
    BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.